Latest issue of Needle looks at growing target class of phagocytic checkpoints, Chinese biotechs developing them, with their increasing share of the drug pipeline. Plus highlight of best translational papers. haystack-science.kit.com/posts/the-need…
Here's the latest issue of The Needle, in which we talk about the recent Science paper on the generation of CAR-T cells in vivo. There is a lot of scientific and commercial activity on this front, and you can read about it in our Newsletter.
lnkd.in/esc_z5Q4
A @statnews analysis shows that the gap in NIH grant awards compared to past years has grown over the past two months, to $4.7 billion.
statnews.com/2025/06/27/des…
We highly recommended subscribing to this newsletter written by two former Nature editors, including our ex-Chief Editor Andy Marshall. The latest issue focuses on mitochondrial disease and covers two recent Nature Biotechnology papers by Dali Li and colleagues
We highly recommended subscribing to this newsletter written by two former Nature editors, including our ex-Chief Editor Andy Marshall. The latest issue focuses on mitochondrial disease and covers two recent Nature Biotechnology papers by Dali Li and colleagues
Latest Needle newsletter is out with a look at mitochondrial disease base editing, a somewhat neglected corner of the gene editing universe . Plus latest targets, therapies and delivery solutions, together with early-stage deals and financings. bit.ly/44fqQeS
This week issue of the Needle takes a look at advances in lipid nanoparticles for organs other than the liver. Financings and deals for preclinical builds remains low, but last week Eli Lilly was busy making deals for antibodies and oligos bit.ly/3FeP2Em
3 Followers 107 FollowingBiopharma. Precision medicine. Life Sciences. Mostly just things I think are cool. Opinions are my own and do not reflect those of my employer.
27K Followers 988 FollowingGenomics PhD student, neurodegeneration & neuroimmune loops. Moderate hereditarian. Views my own, not those of my institution or lab.
318K Followers 2K FollowingPublishing the best of biotech science and business. Find us on Bluesky, Facebook & Instagram. Part of @SpringerNature and @NaturePortfolio.
488 Followers 1K FollowingPMP® | Research Alliances & Innovation | Business Development | Advanced Therapies and Biomedicine | Connecting the dots from @CIMA_unav (formerly @CNTA_CIT)
4K Followers 676 FollowingAssociate Professor @CGM_MGH at @MGH_RI & @HarvardMed
Genome editing / Protein eng. / Molecular medicine 🇨🇦🧬
Kayden-Lambert MGH Research Scholar '23-28
9K Followers 2K FollowingProf. @ Boston University and Wyss Institute. Understanding the natural world by building a synthetic one. website: https://t.co/PyjGQRHoUy
1K Followers 1K FollowingDirector, Cleveland Clinic Genome Center. Utilize genomic science and systems biology to predict drug targets and identify mechanisms for Alzheimer’s disease.
2K Followers 260 FollowingBioLabs @NYULangone is a co-working space for growing life science companies in Hudson Square. Follow us to see the news! https://t.co/hoyDFEb7cV
1K Followers 162 FollowingHarlem Biospace is a biotech incubator, the first of its kind in New York City, to offer affordable shared wet-lab space for competitively-selected entrants.
809 Followers 1K FollowingKIILN (Keystone for Incubating Innovation in Lifesciences Network) is a biotech accelerator in NYC. We aim to support early-stage biotech companies.
10K Followers 401 FollowingBiotech Sell side analyst at @rwbaird. Probability of a false positive = 1 - (1 - alpha value)^n. De omnibus dubitandum est. Inventor of 𝕊𝕒𝕣𝕔𝕒𝕤𝕞 𝔽𝕠𝕟𝕥
345K Followers 1K FollowingViruses, viruses, viruses and vaccines.
V5=3xancestral+1x bivalent+1xXBB
Professor at the Department of Microbiology
Icahn School of Medicine at Mount Sinai
16K Followers 48 FollowingScience and Innovation. Special interest in BioTech, Pharma, Gene Editing and CRISPR 🧬. Sharing my thoughts & 📊 on the Global Economy & Financial Markets. 📈
30K Followers 989 FollowingCEO @VerveTx $VERV; Imagine if a one-time treatment led to permanent lowering of LDL cholesterol: that’s what we are developing to treat heart attack
13K Followers 298 FollowingAtlas Venture invests in early-stage life sciences innovation. We partner with remarkable entrepreneurs to build breakthrough biotech companies.
405K Followers 8K FollowingTexas Medical Center (TMC) Professor-Vaccine Scientist-Author; Member, Philosophical Society of Texas and TAMEST; Dallas Morning News Texan of the Year 2022
4K Followers 1K FollowingWe're a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value for patients and shareholders
171K Followers 709 FollowingThe funder-researcher collaboration and open-access journal for research in the life and biomedical sciences | @eLifeCommunity
2.6M Followers 3K FollowingResearch, News, and Commentary from Nature, the international science journal
For daily science news, get Nature Briefing: https://t.co/wGmQlQ8a4D
19K Followers 2K Followingceo @PerlaraPBC (@ycombinator W16), ceo @epalrestat, ceo @endrarediseases $CURES, evo pharmacologist, mTOR worshipper $RAPTOR, cofounder of K&L
6K Followers 1K FollowingCEO of life sciences accelerator @Xontogeny; Venture Fund Manager w/ Perceptive Advisors; Biopharma career w/ Sarepta, Celgene and Gilead
11K Followers 2K Following#Biotech reporter @SFBusinessTimes; hardcore @Tigers fan; once rolled a 288. Tip me: [email protected], Signal or 415-722-2678. Also find me on bluesky.
5K Followers 420 FollowingFormer CEO @NimbusTx. Board member at multiple companies helping teams discover & develop new medicines for patients. Any tweets are solely my own views.
4.5M Followers 460 FollowingCutting-edge research, news, commentary, and visuals from the Science family of journals. Follow @NewsfromScience for stories from our News team.
120K Followers 781 FollowingBiotech reporter @statnews. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously. On Signal: stataf.54
28K Followers 3K FollowingProgress in science depends on new techniques, new discoveries and new ideas, probably in that order - {Sydney Brenner}. I write about biotech @MIT @techreview
812 Followers 324 FollowingThe Bayh-Dole Coalition is a group of research and scientific organizations dedicated to celebrating and protecting the Bayh-Dole Act.